352 related articles for article (PubMed ID: 33242982)
1. The Effect of Long-Term Atorvastatin Therapy on Carotid Intima-Media Thickness of Children With Dyslipidemia.
Karapostolakis G; Vakaki M; Attilakos A; Marmarinos A; Papadaki M; Koumanidou C; Alexopoulou E; Gourgiotis D; Garoufi A
Angiology; 2021 Apr; 72(4):322-331. PubMed ID: 33242982
[TBL] [Abstract][Full Text] [Related]
2. Carotid intima-media thickness in children with familial hypercholesterolemia.
Kusters DM; Wiegman A; Kastelein JJ; Hutten BA
Circ Res; 2014 Jan; 114(2):307-10. PubMed ID: 24192652
[TBL] [Abstract][Full Text] [Related]
3. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
[TBL] [Abstract][Full Text] [Related]
4. Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial.
Hari P; Khandelwal P; Satpathy A; Hari S; Thergaonkar R; Lakshmy R; Sinha A; Bagga A
Pediatr Nephrol; 2018 Dec; 33(12):2299-2309. PubMed ID: 30091061
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.
Bos S; Duvekot MH; Touw-Blommesteijn AC; Verhoeven AJ; Mulder MT; Watts GF; Sijbrands EJ; Roeters van Lennep JE
Atherosclerosis; 2015 Sep; 242(1):226-9. PubMed ID: 26222903
[TBL] [Abstract][Full Text] [Related]
6. Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
Davidson MH; Rosenson RS; Maki KC; Nicholls SJ; Ballantyne CM; Mazzone T; Carlson DM; Williams LA; Kelly MT; Camp HS; Lele A; Stolzenbach JC
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1298-306. PubMed ID: 24743431
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study).
Ikeda K; Takahashi T; Yamada H; Matsui K; Sawada T; Nakamura T; Matsubara H;
Eur J Prev Cardiol; 2013 Dec; 20(6):1069-79. PubMed ID: 22689416
[TBL] [Abstract][Full Text] [Related]
8. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
[TBL] [Abstract][Full Text] [Related]
9. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.
van Wissen S; Smilde TJ; Trip MD; de Boo T; Kastelein JJ; Stalenhoef AF
Heart; 2003 Aug; 89(8):893-6. PubMed ID: 12860867
[TBL] [Abstract][Full Text] [Related]
10. Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis.
Kent SM; Coyle LC; Flaherty PJ; Markwood TT; Taylor AJ
Clin Cardiol; 2004 Jan; 27(1):17-21. PubMed ID: 14743850
[TBL] [Abstract][Full Text] [Related]
11. Changing characteristics of statin-related cIMT trials from 1988 to 2006.
Davidson MH; Tomassini JE; Jensen E; Neff D; Polis AB; Tershakovec AM
Atherosclerosis; 2016 Mar; 246():121-9. PubMed ID: 26773471
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.
Rodríguez-Borjabad C; Ibarretxe D; Girona J; Ferré R; Feliu A; Amigó N; Guijarro E; Masana L; Plana N;
Atherosclerosis; 2018 Mar; 270():117-122. PubMed ID: 29407879
[TBL] [Abstract][Full Text] [Related]
14. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
16. Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
Braamskamp MJAM; Langslet G; McCrindle BW; Cassiman D; Francis GA; Gagne C; Gaudet D; Morrison KM; Wiegman A; Turner T; Miller E; Kusters DM; Raichlen JS; Martin PD; Stein EA; Kastelein JJP; Hutten BA
Circulation; 2017 Jul; 136(4):359-366. PubMed ID: 28592434
[TBL] [Abstract][Full Text] [Related]
17. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
Ardoin SP; Schanberg LE; Sandborg CI; Barnhart HX; Evans GW; Yow E; Mieszkalski KL; Ilowite NT; Eberhard A; Imundo LF; Kimura Y; Levy D; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy DK; Klein-Gitelman M; Wallace C; Silver RM; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed AM; Thompson SD;
Ann Rheum Dis; 2014 Mar; 73(3):557-66. PubMed ID: 23436914
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis progression in patients with autosomal dominant hypercholesterolemia in clinical practice.
Jarauta E; Mateo-Gallego R; Bea AM; Crespo M; Ballester A; Rubio MV; Baila-Rueda L; Calmarza P; Cenarro A; de Groot E; Civeira F
J Clin Lipidol; 2014; 8(4):373-80. PubMed ID: 25110218
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia.
Nakagomi A; Shibui T; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
J Atheroscler Thromb; 2015; 22(11):1158-71. PubMed ID: 26084792
[TBL] [Abstract][Full Text] [Related]
20. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
